Logo image
Loss of fructose-1,6-bisphosphatase induces glycolysis and promotes apoptosis resistance of cancer stem-like cells: an important role in hexavalent chromium-induced carcinogenesis
Journal article   Open access   Peer reviewed

Loss of fructose-1,6-bisphosphatase induces glycolysis and promotes apoptosis resistance of cancer stem-like cells: an important role in hexavalent chromium-induced carcinogenesis

Jin Dai, Yanli Ji, Wei Wang, Donghern Kim, Leonard Yenwong Fai, Lei Wang, Jia Luo and Zhuo Zhang
Toxicology and applied pharmacology, Vol.331, pp.164-173
09/15/2017
DOI: 10.1016/j.taap.2017.06.014
PMCID: PMC5567692
PMID: 28624442
url
https://doi.org/10.1016/j.taap.2017.06.014View
Published (Version of record) Open Access

Abstract

Hexavalent chromium (Cr(VI)) compounds are confirmed human carcinogens for lung cancer. Our previous studies has demonstrated that chronic exposure of human bronchial epithelial BEAS-2B cells to low dose of Cr(VI) causes malignant cell transformation. The acquisition of cancer stem cell-like properties is involved in the initiation of cancers. The present study has observed that a small population of cancer stem-like cells (BEAS-2B-Cr-CSC) exists in the Cr(VI)-transformed cells (BEAS-2B-Cr). Those BEAS-2B-Cr-CSC exhibit extremely reduced capability of generating reactive oxygen species (ROS) and apoptosis resistance. BEAS-2B-Cr-CSC are metabolic inactive as evidenced by reductions in oxygen consumption, glucose uptake, ATP production, and lactate production. Most importantly, BEAS-2B-Cr-CSC are more tumorigenic with high levels of cell self-renewal genes, Notch1 and p21. Further study has found that fructose-1,6-bisphosphatase (FBP1), an rate-limiting enzyme driving glyconeogenesis, was lost in BEAS-2B-Cr-CSC. Forced expression of FBP1 in BEAS-2B-Cr-CSC restored ROS generation, resulting in increased apoptosis, leading to inhibition of tumorigenesis. In summary, the present study suggests that loss of FBP1 is a critical event in tumorigenesis of Cr(VI)-transformed cells. •A small population of cancer-like stem cells exist in Cr(VI)-transformed cells.•Those cancer-like stem cells are low in ROS levels and resistant to apoptosis.•Those cancer-like stem cells are metabolic inactive and loss of FBP1.•Those cancer-like stem cells initiate and sustain tumor growth.•Forced expression of FBP1 inhibits tumorigenecity of those cancer-like stem cells.
Cancer stem cells Cr(VI) Fructose-1,6-bisphosphatase Metabolism Reactive oxygen species Tumorigenesis

Details

Metrics

Logo image